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Substrate channeling in proline metabolism
Benjamin W. Arentson1, Nikhilesh Sanyal1, and Donald F. Becker1
1Department of Biochemistry, University of Nebraska-Lincoln, Lincoln, NE 68588, USA

Abstract
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Proline metabolism is an important pathway that has relevance in several cellular functions such
as redox balance, apoptosis, and cell survival. Results from different groups have indicated that
substrate channeling of proline metabolic intermediates may be a critical mechanism. One
intermediate is pyrroline-5-carboxylate (P5C), which upon hydrolysis opens to glutamic
semialdehyde (GSA). Recent structural and kinetic evidence indicate substrate channeling of P5C/
GSA occurs in the proline catabolic pathway between the proline dehydrogenase and P5C
dehydrogenase active sites of bifunctional proline utilization A (PutA). Substrate channeling in
PutA is proposed to facilitate the hydrolysis of P5C to GSA which is unfavorable at physiological
pH. The second intermediate, gamma-glutamyl phosphate, is part of the proline biosynthetic
pathway and is extremely labile. Substrate channeling of gamma-glutamyl phosphate is thought to
be necessary to protect it from bulk solvent. Because of the unfavorable equilibrium of P5C/GSA
and the reactivity of gamma-glutamyl phosphate, substrate channeling likely improves the
efficiency of proline metabolism. Here, we outline general strategies for testing substrate
channeling and review the evidence for channeling in proline metabolism.
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2. INTRODUCTION
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It is well known that proline metabolism has important roles in carbon and nitrogen flux and
protein synthesis. Proline metabolism has also emerged as a relevant pathway in other
processes such as cell signaling, cellular redox balance, and apoptosis (1–3). Proline
homeostasis is important in human disease, where inborn errors in proline metabolism are
thought to lead to neurological dysfunctions such as schizophrenia and febrile seizures, as
well as errors in systemic ammonia detoxification and developmental disorders such as skin
hyperelasticity (4–7). Recently it was shown that mutations that disrupt proline biosynthesis
are linked with progeroid features and osteopenia that are part of the autosomal recessive
cutis laxa syndrome (8). In bacteria and plants, proline metabolism is responsive to various
environmental stresses such as drought, osmotic pressure, or ultraviolent irradiation leading
to proline accumulation as a survival mechanism (9–11). Overall proline has become a very
important metabolite that is thought to be involved in many cellular processes.
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Fundamental to understanding the roles of proline metabolism in various processes is
knowledge of the relevant enzymes and mechanisms used to maintain proper proline
homeostasis. In this review, the unique aspect of substrate channeling in proline metabolism
will be explored. Insights into the channeling mechanisms of enzymes responsible for the
catabolism and biosynthesis of proline are helping to reveal the many roles of proline within
the cell. Here we review the structural and kinetic data that support substrate channeling of
P5C/GSA and gamma–glutamyl phosphate in the proline catabolic and biosynthetic
pathways, respectively. The data indicate that both intermediates are channeled, which
increases the efficiency of proline metabolic flux.

3. PROLINE METABOLIC ENZYMES
3.1. Proline catabolism
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The catabolic and anabolic reactions of proline metabolism are shown in Figure 1. The
catabolic pathway generates glutamate from the four electron oxidation of proline, which
occurs in two catalytic steps (12). In the first step, proline dehydrogenase (PRODH; EC
1.5.99.8) uses a flavin adenine dinucleotide (FAD) cofactor as an electron acceptor to
remove two electrons from proline, rendering the intermediate 1-delta-pyrroline-5carboxylate (P5C). P5C then undergoes a non-enzymatic hydrolysis, which opens the ring
structure and generates gamma-glutamate semialdehyde (GSA). Pyrroline-5-carboxylate
dehydrogenase (P5CDH; EC 1.5.1.12) next pulls off two additional electrons from GSA
using nicotinamide adenine dinucleotide (NAD+) to complete the conversion of proline to
glutamate (12).
The PRODH and P5CDH enzymes involved in the oxidation of proline are highly conserved
in both eukaryotes and prokaryotes, but differ in whether they are fused into a bifunctional
enzyme called proline utilization A (PutA). As reviewed by Tanner, PRODH enzymes can
be divided into three branches (13). One branch consists of monofunctional enzymes, where
the PRODH and P5CDH domains are found as separate enzymes. The other two branches
have the PRODH and P5CDH domains on a single PutA polypeptide (13). Originally it was
thought that all prokaryotes contain bifunctional PutAs, and that all eukaryotes contain
monofunctional enzymes. However, it is now known that Gram-positive bacteria contain
monofunctional enzymes, thus limiting PutAs to Gram-negative bacteria (14).

NIH-PA Author Manuscript

Figure 2 summarizes the domain organization of PRODH and P5CDH enzymes.
Monofunctional PRODHs typically are 200–540 amino acid residues in length, while
monofunctional P5CDHs are composed of 400–600 residues. Thermus thermophilus
PRODH and P5CDH are currently the only structures of monofunctional enzymes that have
been solved (PDB ID 2G37, 2EKG, 2BHP, 2BJA) (14–16). PutAs consist of 1000–1350
residues with the P5CDH domain linked to the C-terminal end of the PRODH domain (13).
The two branches of PutA enzymes are distinguished by whether or not PutA also contains
an N-terminal ribbon-helix-helix (RHH) DNA binding domain. PutAs that contain a DNA
binding domain are trifunctional and are generally longer polypeptides than PutAs that lack
a DNA binding domain (17–19). Trifunctional PutAs act as transcriptional repressors—
when cellular proline is scarce, PutA binds DNA and represses expression of the putA and
putP (Na+/proline transporter) genes (20, 21). Regulation of PutA is achieved through a
functional switching mechanism, where the redox state of flavin determines whether PutA is
bound to the DNA and acts as a transcriptional repressor or is peripherally bound to the
membrane where it efficiently catabolizes proline (22).
Recently, the first crystal structure of a complete PutA protein (Bradyrhizobium japonicum)
was solved by Tanner’s group (PDB ID 3HAZ). Previously, the only structures available for
PutA were of the isolated PRODH and DNA binding domains. The PRODH domain
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structure was solved for PutA from Escherichia coli (PDB ID 1K87, 1TJ2, ITIW, 1TJ0,
3ITG) (23–26), and the DNA binding domain of PutA was solved by solution NMR
(Pseudomonas putida) and X-ray diffraction (E. coli) (PDB ID 2JXG, 2GPE, 2RBF) (27–
29). These structures show that the PRODH domain is a conserved beta8alpha8-barrel, while
the P5CDH domain contains a well conserved Rossmann fold domain. The evolutionary
divergence from bifunctional PutA to monofunctional PRODH and P5CDH is of interest
due to substrate channeling between the active sites in bifunctional PutA. Substrate
channeling between monofunctional enzymes would necessitate functional PRODH-P5CDH
interactions, which have not yet been explored.
3.2. Proline biosynthesis
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Proline biosynthesis from glutamate involves three enzymatic steps (Figure 1). The initial
two steps are catalyzed by gamma-glutamyl kinase (GK; EC 2.7.2.11) and gamma-glutamyl
phosphate reductase (GPR; EC 1.2.1.41). GK uses adenosine-5′-triphosphate (ATP) to
generate gamma-glutamyl phosphate, which is subsequently reduced by GPR using
nicotinamide adenine dinucleotide phosphate (NADPH) to produce GSA (12). GSA next
cyclizes to P5C, which is a crossroads intermediate that, in principle, can be converted not
only to proline, but also to ornithine or back to glutamate via P5CDH (12). The reduction of
P5C to proline is catalyzed by P5C reductase (P5CR; EC 1.5.1.2), while the production of
ornithine from P5C requires ornithine aminotransferase (OAT; EC 2.6.1.13), an enzyme that
is important for balancing cellular nitrogen levels (12).
In bacteria and lower eukaryotes such as yeast, GK and GPR are discrete monofunctional
enzymes. In animals and plants, the GK and GPR domains are fused together into the
bifunctional enzyme P5C synthase (P5CS) (Figure 3). The GK and GPR domains are well
conserved in lower eukaryotes and bacteria. The GK domain is normally 250–450 residues
in length with an N-terminal amino acid kinase (AAK) domain. In bacteria, GK contains a
C-terminal pseudo uridine synthase and archaeosine-specific transglycosylase (PUA)
domain, which has no known function (30). It has been suggested, however, that the PUA
domain may enable bacterial GK to have a gene regulatory role (31). The structures of GK
enzymes from E. coli and Campylobacter jejuni have been solved (PDB ID 2J5T, 2AKO)
(32). E. coli GK is composed of an N-terminal catalytic domain made up of eight nearly
parallel beta-sheets sandwiched by two layers of three and four alpha-helices. It is connected
by a linker region to the PUA domain, which contains a distinctive beta sandwich (32).
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GPR typically contains 400–500 residues and consists of an N-terminal Rossmann fold
domain for NADPH binding, a catalytic domain, and an oligomerization domain at the Cterminus (33). The X-ray crystal structure of GPR from Thermotoga maritima reveals that
the catalytic domain has an alpha/beta architecture with a five-stranded parallel beta-sheet
(PDB ID 1O20) (33). To date, no complete structure of bifunctional P5CS has been
reported. However, the structure of the isolated GPR domain (PDB ID 2H5G; unpublished)
from human P5CS is available. The last enzyme of the proline biosynthetic pathway, P5CR,
ranges from 400–500 residues in length and has a conserved N-terminal Rossmann fold for
NADPH binding. Several crystal structures of P5CR have been determined, including the
human form (PDB ID 2GRA) (34). Human P5CR has an active site cleft made of an 8stranded beta-sheet sandwiched by alpha-helices on either side and oligomerizes to form a
decameric structure of dimers (34).

4. INTERMEDIATES OF PROLINE METABOLISM
The P5C/GSA and gamma–glutamyl phosphate intermediates of proline metabolism are
appreciably labile and reactive. Figure 4 shows examples of undesirable fates that can occur
with these intermediates. The instability of the intermediates implies substrate channeling
Front Biosci. Author manuscript; available in PMC 2013 January 01.

Arentson et al.

Page 4

NIH-PA Author Manuscript

may be important for maintaining efficient proline metabolic flux. The intermediate shared
by the catabolic and biosynthetic pathways, P5C/GSA, has been shown to inhibit other
enzymes, react with metabolites, and act as a signaling molecule. GSA has been reported to
inhibit glucosamine-6-phosphate synthase from E. coli, cytidine 5′-triphosphate synthase,
and the amidotransferase domain of carbamoyl phosphate synthetase (35–37). Additionally,
P5C forms adducts with other metabolites such as pyruvic acid, oxaloacetic acid, and
acetoacetic acid (38). P5C can also react with pyridoxal phosphate in patients with type II
hyperprolinemia. Type II hyperprolinemia is characterized by elevated plasma levels of
P5C/GSA due to deficient P5CDH activity (39). The high levels of P5C/GSA generate
inactive adducts with pyridoxal phosphate, leading to lower amounts of functional vitamin
B6 in patients (Figure 4) (38). P5C also acts as a signaling molecule in eukaryotes and is
thought to induce apoptosis by increasing intracellular reactive oxygen species (40, 41).
Altogether, it seems that controlling levels of free P5C/GSA would be beneficial.
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The reactive intermediate in proline biosynthesis is gamma–glutamyl phosphate. The
carbonyl phosphate group is susceptible to nucleophilic attack, resulting in the spontaneous
cyclization of gamma–glutamyl phosphate into 5-oxoproline as shown in Figure 4 (42, 43).
It has been suggested that 5-oxoproline is a neurotoxin. Interstitial injection of 5-oxoproline
into rats produces behavioral and neuropathological effects that resemble Huntington’s
disease (44, 45). The instability of gamma–glutamyl phosphate seems to necessitate its
channeling between GK and GPR during proline biosynthesis.

5. OVERVIEW OF SUBSTRATE CHANNELING
5.1. Rationale for substrate channeling
Substrate channeling is a phenomenon where the product of one reaction is transported to a
second active site without equilibrating into bulk solvent (46). Three mechanisms of
substrate channeling have been defined, two of which are reviewed by Miles et al. (47). The
most common form of substrate channeling occurs when a cavity exists within a protein that
sequesters the intermediate from solvent, allowing for a means of travel between active sites
(47). To date, several enzymes are known to utilize these intramolecular tunnels, with the
classic example being tryptophan synthase (48). The second form of channeling does not use
intramolecular cavities; rather, electrostatic residues on the surface of the enzyme guide the
intermediate from the first active site to the second active site (47). Dihydrofolate reductasethymidylate synthase complex stands as the common example for this form of channeling
(49). A third form of channeling exists in protein complexes such as pyruvate
dehydrogenase, which uses cofactor lipoic acid to transfer substrate to multiple active sites
without contacting solvent (50).
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Substrate channeling has been proposed to be advantageous in the cellular environment for
several reasons, as outlined by Ovadi and others (46, 51). First and foremost it increases the
efficiency of coupled reactions both by preventing the loss of intermediates to diffusion and
by decreasing transit time between active sites. This allows the steady-state flux through the
coupled steps to be attained more rapidly (46). Secondly, it prevents labile intermediates
from decaying and reacting with other metabolites or enzymes within the cell (46). Third,
channeling segregates intermediates that may require a specific environment (e.g., pH) to
retain structure or reactivity. Channels can provide an environment that facilitates an
equilibrium step that normally would be unfavorable in the bulk solution. Finally,
channeling limits intermediates from being siphoned out into competing reactions or
pathways (46).
All of the benefits listed above are not necessarily relevant for every channeling system. In
the proline catabolic pathway, channeling of P5C/GSA may be most critical for making the
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hydrolysis of P5C to GSA more favorable at physiological pH values. The P5C/GSA
equilibrium is highly pH dependent (35). GSA is favored only below pH 6.5 due to
protonation of the pyrrolinium ring, which facilitates the hydrolysis of P5C to GSA. Thus,
one benefit of channeling between PRODH and P5CDH would be to increase the pKa of the
pyrrolinium species above pH 6.5, making the hydrolysis of P5C to GSA more favorable at
physiological pH conditions. If we only consider the P5C/GSA hydrolysis step, substrate
channeling is likely more critical for the proline catabolic pathway than for proline
biosynthesis, since P5C formation is favored at physiological pH. In the proline biosynthetic
pathway, protecting the highly labile gamma–glutamyl phosphate would be a clear benefit of
substrate channeling between GK and GPR.
5.2. Kinetic approaches to test for substrate channeling
Different strategies have been devised to examine whether channeling occurs between
enzymes. Before reviewing the evidence for substrate channeling in proline metabolism, a
short description of various experimental methods is described here.
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5.2.1. Transient time estimation—A common strategy to test for channeling is to
evaluate whether there is a lag time in reaching steady-state formation of the final product in
a coupled assay. Figure 5 shows substrate (S) being converted to the final product (P) via the
coupled action of two enzymes (E1 and E2). The lag time or transient time, Tau, is the time
preceding the build-up to steady-state formation of the final product using the substrate of
the first enzyme (52). If no channeling occurs, Tau should be equal to the ratio of Km/Vmax
of the second enzyme. If the observed lag time is shorter than the Km/Vmax ratio, then it
infers that the intermediate is transferred between the enzymes, E1 and E2. The extent of the
observed lag time may vary among different channeling systems with a shorter transient
time being interpreted as more efficient transfer or channeling (53). Along with steady-state
assays, pre-steady state measurements can also be made to evaluate the lag time prior to
product formation.
5.2.2. Trapping the intermediate—The effect of a reagent that specifically traps the
intermediate species (I, Figure 5) on the kinetics of product formation can also be used to
evaluate channeling. For example, o-aminobenzaldehyde (o-AB) which reacts with P5C to
form a yellow complex can be used as a trapping agent for the PRODH and P5CDH coupled
reaction. o-AB would be anticipated to decrease the overall rate of glutamate formation if no
channeling occurs, while in a channeling system o-AB would have a negligible effect on the
reaction kinetics. Using a third enzyme that competes with E2 for the intermediate can also
be an effective strategy to test for substrate channeling.
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5.2.3. Inactive mutants—Another useful tool is to generate active site mutants of the two
enzymes being studied (Figure 5B). In the case of suspected channeling partners, an active
site mutant (e.g., E2) would be expected to compete with its native counterpart for
interaction with the cognate enzyme (E1). If channeling occurs, adding the inactive E2
mutant in amounts excess to that of native E2 would decrease product formation. If no
channeling occurs, adding the inactive E2 mutant to the coupled enzyme assay would have
no effect on the rate of product formation. This strategy was effectively used to rule out
channeling between aspartate aminotransferase (AAT) and malate dehydrogenase (MDH)
(54).
If the channeling involves two enzyme active sites that are covalently linked, active site
mutants can be used to generate a non-channeling control. Figure 5C illustrates that
combining active site mutants of E1 and E2 creates a mixture of monofunctional enzyme
variants that can only generate product via a diffusion mechanism. The transient times of the
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native enzyme and the mixed enzyme variants can then be compared to distinguish between
channeling and non-channeling mechanisms. This strategy was used recently to demonstrate
channeling in bifunctional PutA.
5.2.4. Designing fusion proteins—Two active sites that are in close proximity can
sometimes exhibit kinetic behavior that resembles direct channeling (55). One strategy for
distinguishing between active channeling and proximity effects is to change the relative
orientation of two active sites, which is important for interacting enzymes (56). A
polypeptide linker can be engineered to covalently link the two enzymes with various
degrees of flexibility and in different orientations (55). If the enzymes are truly channeling,
changes in the orientation of the active sites will have a dramatic effect on the kinetics of
product formation.

6. CHANNELING OF P5C/GSA
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The oxidation of proline to glutamate is catalyzed in consecutive reactions by PRODH and
P5CDH (Figure 1). Avoiding release of P5C/GSA into bulk solvent during proline oxidation
may be beneficial due to the chemical properties of P5C/GSA as discussed in the previous
section. Evidence for channeling P5C/GSA has recently been shown for bifunctional PutA
from B. japonicum (BjPutA). Srivastava et al reported a 2.1 Å resolution crystal structure of
BjPutA (999-residue polypeptide) that reveals an interior channel connecting the PRODH
and P5CDH active sites (PDB ID 3HAZ) (23). BjPutA purifies as a dimer-of-dimers
tetramer. The dimer is the relevant species for discussing channeling and is shown in Figure
6. Both PRODH and P5CDH domains contribute to the formation of the channel, with the
two active sites separated by a distance of 41 Å. The connecting channel appears to start at
the si face of the isoalloxazine ring of FAD and end at the catalytic cysteine (Cys792) of the
P5CDH domain (Figure 6). Within the channel, the central cavity is lined by fifteen basic
residues (Lys and Arg) and seventeen acidic residues (Glu and Asp), imparting a hydrophilic
nature to the channel. Each of the PutA protomers has an individual channel connecting
PRODH and P5CDH active sites.

NIH-PA Author Manuscript

Interestingly, the dimeric structure of BjPutA seems to be critical for sealing the channel and
minimizing access to bulk solvent. A beta-flap protrudes from the P5CDH domain (beta
strands, residues 628–646, 977–989) from one protomer and forms intermolecular
interactions with the P5CDH domain of the second protomer (Figure 6). This beta-flap is
structurally conserved in Thermus thermophilus P5CDH (PDB ID 1UZB, residues 163–
174,506–516) as well as a class I aldehyde dehydrogenase isolated from sheep liver (PDB
ID 1BXS, residues 147–159, 486–498) (57) (16) and is sometimes referred to as the
oligomerization domain. Thus, in BjPutA, the beta-flap not only helps stabilize dimer
formation but also is important for sealing the central cavity.
Along with these structural features of channeling, kinetic evidence for channeling was also
reported for BjPutA by Srivastava et al. Different experiments have provided strong
evidence for channeling. First, the amount of P5C released into bulk solvent was quantitated
by using o-aminobenzaldehyde (o-AB) as a trapping agent. P5C and o-AB react to form a
yellow complex that can be monitored at 443 nm (58). In the absence of NAD+, the P5CDH
domain is inactive and leads to significant release of P5C into the bulk solvent, as detected
by the yellow complex formation. In the presence of NAD+, however, the P5CDH domain is
active, resulting in significantly lower o-AB-P5C complex formation, as the majority of P5C
is converted into glutamate (23). The apparent fraction of P5C that is channeled in BjPutA
from PRODH to P5CDH was estimated to be 0.7 by these measurements.
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Substrate channeling in BjPutA was also examined by estimating the transient time to reach
steady-state turnover of the second enzyme, P5CDH, using proline as a substrate (23, 59,
60). With native BjPutA, steady-state formation of NADH (product of the P5CDH reaction)
occurred without any apparent lag time (23). The absence of a lag time in the approach to
steady-state indicates substrate channeling. A non-channeling control was also analyzed
using active site mutants of BjPutA that lack PRODH (R456M) and P5CDH (C792A)
activity (23). The R456M mutation inactivates PRODH but does not impair P5CDH activity,
whereas the C792A mutation inactivates P5CDH but does not impair PRODH activity. The
mixture of these monofunctional variants was used as a non-channeling control as described
above. In this non-channeling control, P5C formed by the C792A variant must diffuse out
into bulk solvent and bind to the R456M variant before NADH is formed. In the assays with
the non-channeling variants, a lag time of about seven minutes for NADH formation was
observed (23). The observed lag time was similar to the theoretical Tau value calculated
from the independent PRODH activity and P5CDH kinetic parameters. An example of these
steady-state assays is shown in Figure 7. Figure 7 illustrates the clear difference in the
kinetic behavior of native BjPutA and the non-channeling control. With native BjPutA,
NADH formation is observed without a lag time, while with the mixed variants a lag time of
around 6.5 minutes is observed. The results from these assays are consistent with a substrate
channeling mechanism in BjPutA. Kinetic profiles of native BjPutA and the mixed variants
were also compared by rapid-reaction kinetics under anaerobic, single-turnover conditions.
Rapid mixing of native BjPutA and proline generated NADH with no apparent lag time. For
the non-channeling variants, a 10 s lag time for NADH formation was observed after mixing
the enzymes with proline. These results show native BjPutA efficiently channels P5C/GSA.
Evidence for channeling in PutA has also been reported from Salmonella typhimurium PutA
(StPutA). Similar to EcPutA, StPutA contains the N-terminal DNA binding domain and is
thus trifunctional. Maloy et al. demonstrated that the P5CDH domain shows a 14-fold
greater steady-state production of NADH using P5C generated endogenously from proline
by PRODH, as compared to exogenously added P5C (61). In addition, they showed
exogenous P5C was unable to compete against endogenous P5C. Due to a lack of structural
information on trifunctional PutAs, it is not clear whether a channel similar to that
characterized in BjPutA exists. Future structural and kinetic experiments will need to be
performed to fully address the channeling mechanism in trifunctional PutAs.

7. CHANNELING OF GAMMA-GLUTAMYL PHOSPHATE
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As mentioned previously, channeling of the intermediate gamma-glutamyl phosphate would
be beneficial because of its instability. Channeling of gamma-glutamyl phosphate is also
implicated by the fusion of GK and GPR in bifunctional P5CS. Kinetic data have existed for
over forty years suggesting that a complex forms between bacterial GK and GPR in order to
conceal gamma-glutamyl phosphate from solvent (62, 63). A typical assay to measure GK
activity is to add hydroxylamine along with the substrates, glutamate and ATP.
Hydroxylamine reacts with the product gamma-glutamyl phosphate to make gammaglutamyl hydroxamate, which can be measured at 535 nm (62). Multiple groups have
documented that GK activity is dependent on the presence of GPR. GK is inactive or
exhibits very low activity in the absence of GPR, suggesting GPR is required for GK
activity (42, 43, 62, 64, 65). It was found that a 10:1 GPR:GK ratio was necessary to obtain
maximal GK activity, indicating that a GK/GPR complex forms with excess GPR (64). To
test for a complex, Smith et al. tried incubating different ratios of bacterial GK and GPR,
then looked for co-elution of the enzymes by chromatography (64). Both proteins eluted
separately meaning either a complex does not form or complex formation is transient and is
dependent on substrate binding. Other work suggesting a GK-GPR complex includes assays
which contained GK and GPR, but lacked NADPH, the cofactor necessary for GPR activity
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(43). In this case the GPR enzyme was inactive, but it still activated GK. GK has also been
shown to be activated by incubation with GPR mutants, further demonstrating that GK
activation by GPR does not require GPR activity (66). Other experiments that have explored
GK/GPR interactions include Chen et al., who created a mutant GK/GPR fusion protein that
was able to over-produce proline, making the host E. coli strain more resistant to osmotic
stress (67). While this work does not support channeling directly, it does show that
enhancing the proximity of two active sites can significantly increase the efficiency of a
metabolic pathway (67).
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Structural data supporting channeling is not directly available for GK and GPR enzymes
(68). Figure 8 shows the individual structures of E. coli GK (EcGK) and T. maritima GPR
(TtGPR). Marco-Marin et al. modeled a possible interaction between monofunctional GK
and GPR, showing GPR in both an open and closed conformation, depending on the binding
status of the substrate (32). The model shows a tetrameric form of GK from E. coli
complexed with a dimer of GPR from T. maritima (32). In solving the crystal structure
EcGK, Marco-Marin et al. noted that GK was well suited for channeling (32). They
suggested that channeling is possible if the GK and GPR active sites are positioned so that
the active site cysteine of GPR is able to react with gamma-glutamyl phosphate while still
bound at the GK active site. A complex as described would allow for a favorable
environment and timely transfer of gamma-glutamyl phosphate to the second active site,
thereby preventing cyclization to 5-oxoproline (32). Additionally it has been suggested that
leucine zipper motifs found in the GK and GPR domains of plants, as well as the GK and
GPR enzymes of some bacteria are evidence for a functional complex (69). The leucine
zipper of plant P5CS may help with oligomerization or it may be an artifact of evolution.
Several domain swapping experiments have shown that leucine zippers mediate proteinprotein dimerization in eukaryotic and prokaryotic enzymes. Thus, the leucine zippers in
bacterial GK and GPR enzymes and plant P5CS may support a possible channeling complex
(70).

8. SUMMARY
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Proline metabolism has become a very important area of study due to its involvement in
many different cellular processes from maintaining redox balance to countering
environmental stress. As described in this review, substrate channeling is a relevant
mechanism in proline metabolism for translocating important intermediates between active
sites. Rationale for substrate channeling in proline metabolism is two-fold. First, the
equilibrium for the hydrolysis of P5C to GSA is unfavorable at physiological pH, indicating
channeling may be necessary to increase the overall conversion efficiency of proline into
glutamate. Second, P5C/GSA and gamma-glutamyl phosphate are reactive and labile
intermediates. Channeling of these intermediates would protect against the formation of
unwanted products, such as 5-oxoproline from gamma-glutamyl phosphate.
Future kinetic and structural studies are important for understanding the mechanisms of
substrate channeling in proline metabolism. In proline catabolism, BjPutA provides
structural and kinetic data supporting channeling, but more work needs to be done on
trifunctional and monofunctional enzymes. Substrate channeling in PutAs suggests that
bacteria have evolved a strategy to limit the availability of P5C to other competing
pathways. P5C is at the crossroads of important metabolic pathways, which include proline
oxidation, urea cycle, TCA cycle via glutamate, and the proline biosynthetic pathway (71).
Substrate channeling by PutA may help maintain flux through the proline oxidative
pathway, which would be especially important under poor nutrient conditions in cells
starved for nitrogen and glutamate and other downstream products such as alpha–
ketoglutarate. Whether P5C/GSA is channeled in Gram-positive bacteria and eukaryotes is
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not yet known. Studies of PRODH-P5CDH coupled kinetics and potential PRODH-P5CDH
interactions are needed to address channeling between monofunctional PRODH and P5CDH
enzymes. In proline biosynthesis, evidence for interactions between monofunctional GPR
and GK has been reported, but structural evidence for channeling in bifunctional P5CS is
currently not available. Although channeling interactions between GK and GPR seem likely
and are supported by several studies, additional work is required to define the channeling
pathway and mechanisms in proline biosynthesis. To date, a full-length structure of P5CS
has not been reported. Solving a crystal structure of P5CS would be a significant step toward
understanding channeling of gamma-glutamyl phosphate. Not only would a complete
structure of P5CS act as a template for modeling the interaction between monofunctional
GK and GPR, but it could also be used to identify cavities within the protein that may act as
channels for transporting gamma-glutamyl phosphate between active sites.
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Figure 1.

Reactions of the proline metabolic pathway. In the catabolic pathway, proline is converted to
glutamate via a four electron oxidation process. Proline dehydrogenase (PRODH) performs
the first oxidative step, resulting in the intermediate pyrroline-5-carboxylate (P5C). P5C is
subsequently hydrolyzed to glutamic semialdehyde (GSA), which is then further oxidized by
P5C dehydrogenase (P5CDH) to generate glutamate. In Gram-negative bacteria, PRODH
and P5CDH are fused together on a bifunctional enzyme called proline utilization A (PutA).
Proline anabolism begins with phosphorylation of glutamate by gamma-glutamyl kinase
(GK) to generate gamma-glutamyl phosphate (gamma-GP). gamma-GP is reduced by
gamma-glutamyl phosphate reductase (GPR) to GSA, which cyclizes to form P5C. P5C is
then reduced to proline via pyrroline-5-carboxylate reductase (P5CR). In higher eukaryotes
such as plants and animals, GPR and GK are fused together in the bifunctional enzyme
pyrroline-5-carboxylate synthase (P5CS).
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Figure 2.
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Domain mapping of PRODH and P5CDH from E. coli (EcPutA), B. japonicum (BjPutA),
and T. thermophilus. In PutAs, the PRODH and P5CDH domains are connected by a linker
region (L). Trifunctional PutAs such as EcPutA also have a DNA binding domain (D).
TtPRODH and TtP5CDH are separate enzymes (monofunctional) in the Gram-positive
bacteria, T. thermophilus.
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Figure 3.

Domain mapping of monofunctional gamma-glutamyl phosphate reductase (EcGPR) and
gamma-glutamyl kinase (EcGK) enzymes from E. coli and bifunctional pyrroline-5carboxylate synthase (P5CS) from Homo sapiens. M, putative mitochondrial signaling
peptide, BD, binding domain for glutamate and ATP, O, oligomerization domain, and PUA,
pseudo uridine synthase and archaeosine-specific transglycosylase domain with no known
function in EcGK.
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Figure 4.

Side reactions of intermediates pyrroline-5-carboxylate (P5C) and gamma-glutamyl
phosphate (gamma-GP). (A) P5C can deactivate pyridoxal phosphate by forming an adduct,
resulting in vitamin B6 deficiency in individuals with hyperprolinemia type II. The P5Cpyridoxal phosphate adduct structure is from reference 38. (B) gamma-GP can cyclize and
dephosphorylate to form 5-oxoproline, which is suggested to be a neurotoxin in rats.
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Figure 5.
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Strategies for examining substrate channeling. (A) Transient time analysis of a coupled
reaction involving two enzymes, E1 and E2, which convert substrate A into product C. A
trapping agent can also be used to test whether intermediate B is released into bulk solvent
during the reaction. (B) Inactivation of one of the enzyme pairs by site-directed mutagenesis.
If channeling occurs, adding inactive E2 would disrupt the active E1–E2 complex resulting
in lower steady-state activity. (C) Testing channeling in bifunctional enzymes. Inactivation
of the individual domains results in monofunctional variants that can only catalyze the
coupled reaction via a diffusion mechanism. The mixture of monofunctional variants is thus
a non-channeling control.
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Figure 6.

Structure of dimeric BjPutA shown in ribbon representation. The PRODH domain (red) and
the P5CDH domain (orange) of each protomer are connected by a linker region (green).
Active site residues (Arg456, Cys792), FAD and NAD+ are displayed as sticks. β-flap of
each protomer is colored as magenta. The substrate channel of each BjPutA protomer is
shown as blue surface. This model was made using PyMol, CAVER and PDB 3HAZ.
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Figure 7.
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Example of transient time analysis of BjPutA. Steady-state formation of NADH using
proline as a substrate by native BjPutA (solid black curve) and an equimolar mixture of
monofunctional variants R456M and C792A (solid grey curve). The mixture of the
monofunctional variants serves as a non-channeling control. The dotted line represents the
extrapolation used for estimating the lag-time. Native BjPutA shows no apparent lag in
NADH formation, while a lag time of about 6.5 min is observed for the non-channeling
control. The dashed line overlaying the grey curve of the non-channeling control reaction
was simulated using the kinetic parameters of PRODH and P5CDH as described previously
and the following equation: [NADH] = v1t + (v1/v2)Km(e−v2t/Km − 1) (21, 72). Assays were
performed at pH 7.5.
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Figure 8.
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Structures of GPR from T. maritima (TmGPR) and GK from E. coli (EcGK). EcGK is
shown as a dimer with one monomer shown in surface representation and the other
monomer as a ribbon cartoon illustration. Glutamate is shown as spheres in the substrate
binding pocket, which is solvent accessible. Only one monomer of GPR (open
conformation) is shown, which contains three domains: NADPH binding domain (yellow),
catalytic domain (blue) with the catalytic cysteine shown in spheres, and the oligomerization
domain (black). The solvent-exposed glutamate binding pocket of GK suggests that the
gamma-glutamyl phosphate intermediate would be accessible to GPR in a potential GKGPR complex. A GK-GPR complex in which the catalytic domain of GPR is aligned with
the glutamate binding pocket of GK has been proposed and modeled by Marco-Marin et al.
(32). Models shown here were made using PyMol and PDBs 2J5T (EcGK) and 1O20
(TmGPR).
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